Introduction
In England and Wales, the mortality from drug poisoning amongst those patients admitted alive to hospital is less than 1 %. However, if only severely intoxicated patients are considered a different pattern emerges, with mortality rates of 14% (Volans et al., 1977) and 21 % (Hampel and Widdop, 1978) being reported in 2 recent studies. For such patients, extra-corporeal haemoperfusion may reduce the period of coma and hence morbidity and mortality.
The original haemoperfusion devices contained uncoated activated charcoal. Although effective in removing the drug from the circulation, unacceptable side effects of thrombocytopenia, fibrinogen loss and pyrogen reactions were observed (Yatzidis et al., 1965) . Various protective coatings have therefore been applied to the charcoal particles in order to make the systems more bio-compatible.
The authors have used one such device with an acrylic-hydrogel as the coating system and another in which the uncoated charcoal particles have been attached to a fixed-bed (Vale et al., 1975a; Volans et al., 1977; Hampel and Widdop, 1978) . This paper describes an experience in treating patients with a third type of charcoal haemoperfusion column in which the particles are coated with cellulose acetate.
Patients and methods Patient selection
As in the other series (Vale et al., 1975a (Vale et al., , 1975b Volans et al., 1977; Hampel et al., 1980) patients were selected for treatment on the basis of clinical features of severe intoxication in the presence of high plasma drug concentrations. These clinical criteria can be subdivided into (a) severe poisoning (Grade IV coma, respiratory depression, hypotension); (b) prolonged coma with complications such as pneumonia; and (c) suspected brain death following a cardiac or respiratory arrest.
In all cases a full toxicological screen was performed before haemoperfusion, and quantitative plasma assays by specific gas-chromatographic methods were carried out for those drugs which were detected.
Haemoperfusion techniques
An arterio-venous shunt was fashioned between the radial artery and a suitable forearm vein. Skin incisions were kept small in order to minimize bleeding. The patient then received an i.v. injection of 10 000 units of heparin followed by a continuous infusion adjusted to produce a plasma heparin concentration of 2 u./ml. The patient's blood was pumped through a 300-g cellulose acetate-coated charcoal column (Adsorba 300C, Gambro Ltd, Hechingen, West Germany) which had been flushed with one litre of saline containing 1000 units of heparin. At the end of haemoperfusion, heparinization was reversed by an i.v. injection of protamine sulphate. Blood flows of 150-300 ml/min were The plasma drug concentrations at initial screening, at the start and end of haemoperfusion, together with the plasma clearance and the calculated total amount of drug removed are shown in Table 2 . Six of the patients received a single haemoperfusion, whilst one received 2 treatments separated by 5 hr, the first using a cellulose acetate-coated column and the second an acrylic hydrogel-coated column. The cellulose acetate-coated column failed to lower the plasma drug concentration in this patient. This was probably a reflection of continued absorption of drug from the intestine or redistribution of drug from the tissues into the blood since the clearance data indicated that the drug was being removed at a somewhat faster rate than that achieved with the second column.
Platelet counts were performed in 5 of the 7 patients. The fall at 30 min after starting haemoperfusion ranged from 6-7 to 64-3 % with a mean of 34-6 %. By the end of the procedure no platelet count was more than 30% below the pre-perfusion values.
Six of the 7 patients showed marked lightening of coma during this active treatment, the mean time taken to respond to painful stimuli being 9-2 hr (range 2 hr 10 min to 12 hr). Two of these patients recovered uneventfully, one had a small rightsided pleural effusion caused by a misplaced supraclavicular catheter inserted before haemoperfusion, and 2 other patients developed high temperatures. In one case this was associated with a severe chest infection, whilst in the other case there was no obvious cause of fever.
The 7th patient, who suffered a cardio-respiratory arrest on admission to hospital and before haemoperfusion had started, failed to regain consciousness despite a fall in total plasma barbiturate concentration from 51-6 mg/l to 19-5 mg/l after 17 5 hr of treatment. The following day he began to respond to 
Discussion
Several charcoal haemoperfusion devices are now available commercially. These differ with regard to column design, the type and quantity of charcoal and the nature of the protective coating material. The performance of these devices must be judged on their ability to clear drugs from the circulation, their effects on the blood elements and their overall clinical safety. In all these respects, the cellulose acetate column was comparable to the devices which the authors have used previously.
Although there were no deaths in this series it would not be justified to compare these results directly with other series of similarly poisoned patients in whom there was a high mortality (Volans et al., 1977; Hampel and Widdop, 1978 
